About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Miami | 180 Studies

Clinical Trials Prostate CancerMiami

Prostate Cancer Clinical Trials in Miami

Find 180 clinical trials for prostate cancer near Miami, Florida. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Miami

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 180 trials

CompletedCPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersThis is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in…NCT03454451·Tucson, Arizona and 26 others TerminatedExpanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)The SPERA trial is designed to 1. provide satraplatin to physicians with patients who have hormone refractory prostate cancer (HRPC) which has progressed following unlimited…NCT00450970·Birmingham, Alabama and 120 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy, such as docetaxel, prednisone, and atrasentan work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00134056·Mobile, Alabama and 553 others

CompletedA Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane RegimenThis Phase III, multicenter, randomized, open-label study will evaluate the safety and efficacy of atezolizumab (anti-programmed death-ligand 1 \[anti-PD-L1\] antibody) in…NCT03016312·Duarte, California and 157 others

CompletedMRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate CancerThe hypotheses of this study are: 1.NCT01411319·Miami, Florida

CompletedClinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)The purpose of this research study is investigate a new and validated urine test which predicts the likelihood of high grade prostate cancer on an initial prostate biopsy The…NCT03031418·Fort Myers, Florida and 17 others

Active not recruitingA Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)The purpose of this study is to learn whether adding abemaciclib to abiraterone plus prednisone prolongs the time before prostate cancer gets worse.NCT05288166·Prescott, Arizona and 265 others

CompletedMy Health Day by Day (Mi Salud Dia a Dia)The purpose of this study is to is to evaluate how Cognitive Behavioral Stress Management (CBSM) targets (e.g., anxiety reduction, cognitive reappraisal, coping, emotional…NCT04545021·Miami, Florida

CompletedProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate CancerThis was an open-label Phase 1b/2 study involving oral administration of CPI-1205 in combination with either enzalutamide or abiraterone/prednisone in male patients with…NCT03480646·Anchorage, Alaska and 40 others

RecruitingThe Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)The purpose of this study is to evaluate the efficacy and safety of 177Lu-TLX591 in patients with metastatic castration-resistant prostate cancer who have progressed following…NCT06520345·Orange, California and 32 others

TerminatedPK and Dose Escalation and Expansion Study of DST-2970This is a Phase I multi-center, open-label, study of DST-2970 to determine the MTD, overall safety/tolerability, PK/pharmacodynamic parameters, and efficacy in prostate cancer…NCT04291664·Miami, Florida and 4 others

Active not recruitingWATER IV Prostate CancerThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk…NCT06651632·Chandler, Arizona and 36 others

CompletedCopper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate CancerThis is a prospective, open-label Phase 3 study to evaluate copper Cu 64 PSMA I\&T injection for PET/CT imaging in patients with recurrent prostate cancer after radical…NCT06235099·Fullerton, California and 30 others

RecruitingDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid TumorsThis study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.NCT06239194·Denver, Colorado and 5 others

CompletedCognitive Behavioral Stress Management (CBSM) & Prostate CancerThe purpose of this study is to test a stress management program for men with early-stage prostate cancer.NCT05486754·Miami, Florida

TerminatedPositive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate CancerThe primary purpose of this research is to describe patient characteristics predictive of an imaging study positive for distant metastases in patients with castration-resistant…NCT01981109·Anchorage, Alaska and 57 others

Completed64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)The aim of this study is to determine the safety and efficacy of 64Cu-SAR-BBN and determine the ability of 64Cu-SAR-BBN Positron emission tomography (PET)/computed tomography (CT)…NCT05407311·Los Angeles, California and 7 others

CompletedBicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerThis randomized phase II trial is studying bicalutamide, goserelin, or leuprolide acetate to see how well they work when given with or without cixutumumab in treating patients…NCT01120236·Fairbanks, Alaska and 169 others

CompletedPhase III Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate CancerThe VIABLE study sought to confirm the hypothesis that the combination of docetaxel with DCVAC/PCa followed by a maintenance therapy with DCVAC/PCa would improve overall survival…NCT02111577·Mobile, Alabama and 176 others

CompletedA Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to determine whether the amount of time before disease progression can be prolonged in participants with metastatic castration-resistant prostate…NCT05848011·Miami, Florida and 60 others

PreviousPage 7 of 9Next

Other Conditions in Miami

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma